[go: up one dir, main page]

WO2009120657A3 - Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents - Google Patents

Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents Download PDF

Info

Publication number
WO2009120657A3
WO2009120657A3 PCT/US2009/038027 US2009038027W WO2009120657A3 WO 2009120657 A3 WO2009120657 A3 WO 2009120657A3 US 2009038027 W US2009038027 W US 2009038027W WO 2009120657 A3 WO2009120657 A3 WO 2009120657A3
Authority
WO
WIPO (PCT)
Prior art keywords
monoclonal antibodies
therapeutic agents
antibodies against
human monoclonal
amyloid beta
Prior art date
Application number
PCT/US2009/038027
Other languages
French (fr)
Other versions
WO2009120657A2 (en
Inventor
Moses Rodriguez
Larry R. Pease
Arthur E. Warrington, Jr.
Nilufer Taner
Original Assignee
Mayo Foundation For Medical Education And Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation For Medical Education And Research filed Critical Mayo Foundation For Medical Education And Research
Publication of WO2009120657A2 publication Critical patent/WO2009120657A2/en
Publication of WO2009120657A3 publication Critical patent/WO2009120657A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Materials and methods for identifying human natural anti-Aβ autoantibodies, as well as materials and methods for using such antibodies to treat Alzheimer's disease.
PCT/US2009/038027 2008-03-26 2009-03-24 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents WO2009120657A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3960308P 2008-03-26 2008-03-26
US61/039,603 2008-03-26

Publications (2)

Publication Number Publication Date
WO2009120657A2 WO2009120657A2 (en) 2009-10-01
WO2009120657A3 true WO2009120657A3 (en) 2009-12-17

Family

ID=41114624

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/038027 WO2009120657A2 (en) 2008-03-26 2009-03-24 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents

Country Status (1)

Country Link
WO (1) WO2009120657A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030185827A1 (en) * 1994-04-29 2003-10-02 Mayo Foundation Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030185827A1 (en) * 1994-04-29 2003-10-02 Mayo Foundation Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GEYLIS V. ET AL.: "Human monoclonal antibodies against amyloid-beta from healthy adults", NEUROBIOL. AGING, vol. 26, no. 5, May 2005 (2005-05-01), pages 597 - 606 *
GEYLIS V. ET AL.: "Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies", AUTOIMMUN. REV., vol. 5, no. 1, January 2006 (2006-01-01), pages 33 - 39 *
HOEW, C. L. ET AL.: "Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody", NEUROBIOL. DIS., vol. 15, no. 1, February 2004 (2004-02-01), pages 120 - 131 *
WARRINGTON A. E. ET AL.: "Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis", PROC. NATL. ACAD. SCI. U S A, vol. 97, no. 12, 6 June 2000 (2000-06-06), pages 6820 - 6825 *

Also Published As

Publication number Publication date
WO2009120657A2 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
AU2018256498A1 (en) Antibodies to amyloid beta
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
EA201270813A1 (en) ANTIBODIES TO N3pGlu BETA AMYLOID PEPTIDE AND THEIR APPLICATION
CY1115906T1 (en) HUMANITIZED ANTIBODIES AGAINST BETA AMYLOID
MY164376A (en) Phosphospecific antibodies recognizing tau
EA201000644A1 (en) ANTIBODIES FOR THE TREATMENT AND PREVENTION OF THE ALZGEIMER'S DISEASE AND THEIR APPLICATION
EA201171388A1 (en) HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLARY FORM OF BETA AMYLOID PEPTIDE
WO2009048538A3 (en) Use of anti-amyloid beta antibody in ocular diseases
MX354662B (en) Phosphospecific antibodies recognising tau.
MX356800B (en) Humanized tau antibody.
WO2009149486A3 (en) Compounds for treating beta-amyloidoses
EA201100062A1 (en) CONNECTIONS AND METHODS OF MODELING RECEPTORS ASSOCIATED WITH PROTEIN G
UA107490C2 (en) TNF-α-Binding Protein
MX2009012950A (en) Humanized antibodies to aãŸ(20-42) globulomer and uses thereof.
WO2009048539A3 (en) Use of anti-amyloid beta antibody in ocular diseases
TW200635608A (en) Aβ antibodies for use in improving cognition
TW200635607A (en) Humanized Aβ antibodies for use in improving cognition
MX341369B (en) Safe and functional humanized anti beta-amyloid antibody.
UA101167C2 (en) Pharmaceutical composition useful for the treatment of ocular disease
EA201001695A1 (en) APPLICATION OF EPOTHILON D FOR THE TREATMENT OF DISEASES ASSOCIATED WITH TAU-PROTEIN
CY2022028I1 (en) HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USES IN THE TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES
WO2008122441A3 (en) Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
WO2006014638A3 (en) ANTIBODIES TO CROSS-LINKED AMYLOID β OLIGOMERS
PH12012501743A1 (en) Antigen binding proteins specific for serum amyloid p component
CY1114604T1 (en) HUMANIZED ANTIBODY AGAINST AMYLOID BETA

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09725118

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09725118

Country of ref document: EP

Kind code of ref document: A2